New Psychedelic Drug Shows Rapid Relief from Depression
Researchers found a single dose of intravenous dimethyltryptamine (DMT) significantly reduced symptoms of depression within weeks. DMT has a short half-life, making it more practical for clinical settings than traditional psychedelics. The study included 34 patients with moderate-to-severe depression who didn’t respond to other treatments. After one dose, participants showed rapid improvement that lasted up … Read more